Instrument Inactif

Communiqués Insite Vision Inc.

Actions

INSV

US4576601086

Produits pharmaceutiques

Cours en clôture OTC Bulletin Board Autres places de cotation
- ^USD	-

02/02/15	Insite Vision : Nicox en hausse après un accord avec Site Vision	RE
02/02/15	Insite Vision : Nicox-Accord de licence avec InSite Vision en Europe	RE

Communiqués

15/09/15	InSite Vision : and Sun Pharma Enter into Merger Agreement	BU
03/09/15	InSite Vision : Receives Second Unsolicited Acquisition Proposal for $0.35 per Share From a Global Pharmaceutical Company	BU
03/09/15	InSite Vision : Announces New Date for Special Stockholder Meeting	BU
02/09/15	InSite Vision : Named in BromSite Patent Lawsuit; Company Believes Lawsuit Is Without Merit	BU
21/08/15	InSite Vision : Determines that an Unsolicited Offer from a Multi-National Pharmaceutical Company to Acquire InSite for $0.25 in Cash Constitutes a “Company Superior Proposal”	BU
17/08/15	InSite Vision : Announces FDA Acceptance of NDA Filing for BromSite™ (0.075% bromfenac)	BU
12/08/15	InSite Vision : Announces Date for Special Stockholder Meeting	BU
11/08/15	Insite Vision : Reports Second Quarter 2015 Financial Results	BU
10/08/15	InSite Vision : Receives Unsolicited Proposal from a Multi-National Pharmaceutical Company	BU
11/06/15	Insite Vision : SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of InSite Vision Inc. And Encourages Investors To Contact The Firm For Additional Information	PR
11/06/15	Insite Vision : SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of InSite Vision Inc. of Commencement of an Investigation Regarding the Fairness of the Sale of the Company to QLT Inc.	BU
11/06/15	INSITE VISION : SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to QLT Inc.	BU
11/06/15	InSite Vision : Announces Completion of the New Drug Application Submission to the U.S. FDA for BromSite	BU
10/06/15	Insite Vision : EQUITY ALERT: The Rosen Law Firm Announces Investigation of Insite Vision Inc. Concerning its Proposed Sale to QLT Inc.	BU
12/05/15	InSite Vision : Reports First Quarter 2015 Financial Results	BU
07/05/15	InSite Vision : to Report First Quarter 2015 Results on May 14, 2015	BU
17/03/15	InSite Vision : Announces Settlement of Patent Infringement Lawsuit Against Mylan Pharmaceutical, Inc.	BU
17/02/15	InSite Vision : to Report Fourth Quarter and Year-End 2014 Results on February 17, 2015	PU
17/02/15	InSite Vision : Reports Fourth Quarter and Year-End 2014 Financial Results	BU
10/02/15	InSite Vision : to Report Fourth Quarter and Year-End 2014 Results on February 17, 2015	BU
02/02/15	InSite Vision : Announces License Agreement for AzaSite®, AzaSite Xtra™ and BromSite™ in Europe, Middle East and Africa	BU
19/12/14	InSite Vision : Announces Date for Annual Stockholder Meeting	BU
05/11/14	InSite Vision : Reports Third Quarter 2014 Financial Results	BU
29/10/14	InSite Vision : to Report Third Quarter 2014 Financial Results on November 5, 2014	BU
13/08/14	InSite Vision : Reports Second Quarter 2014 Financial Results	BU